Longitudinal retinal layer changes in preclinical Alzheimer’s disease

Autor: Mara ten Kate, Frank D. Verbraak, H. Stevie Tan, Adriaan A. Lammertsma, Dorret I. Boomsma, Pieter Jelle Visser, Anouk den Braber, Jori Tomassen, Jacoba A. van de Kreeke, Maqsood Yaqub, Bart N.M. van Berckel, Elles Konijnenberg, Hoang Ton Nguyen

Publikováno v: Acta Ophthalmologica
Acta Ophthalmologica, 99(5), 538-544. Wiley-Blackwell
van de Kreeke, J A, Nguyen, H T, Konijnenberg, E, Tomassen, J, den Braber, A, ten Kate, M, Yaqub, M, van Berckel, B, Lammertsma, A A, Boomsma, D I, Tan, H S, Visser, P J & Verbraak, F D 2021, ' Longitudinal retinal layer changes in preclinical Alzheimer’s disease ', Acta Ophthalmologica, vol. 99, no. 5, pp. 538-544 . https://doi.org/10.1111/aos.14640
Van De Kreeke, J A, Nguyen, H T, Konijnenberg, E, Tomassen, J, den Braber, A, Kate, M, Yaqub, M, Berckel, B, Lammertsma, A A, Boomsma, D I, Tan, H S, Visser, P J & Verbraak, F D 2021, ' Longitudinal retinal layer changes in preclinical Alzheimer’s disease ', Acta Ophthalmologica, vol. 99, no. 5, pp. 538-544 . https://doi.org/10.1111/aos.14640

Purpose: Several studies found reduced retinal thickness on optical coherence tomography (OCT) in Alzheimer’s disease (AD), even in preclinical stages, labelling this technique of interest as biomarker. In this study, we examine retinal thickness c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b511b9389981067d29d3d6f15bdadccf
http://europepmc.org/articles/PMC8451744

Retinal layer thickness in preclinical Alzheimer's disease

Autor: Dorret I. Boomsma, Elles Konijnenberg, Hoang-Ton Nguyen, Lyduine Collij, Mara ten Kate, Jurre den Haan, Frank D. Verbraak, Maqsood Yaqub, Hendra Stevie Tan, Jori Tomassen, Pieter Jelle Visser, Bart N.M. van Berckel, Anouk den Braber, Jacoba A. van de Kreeke, Adriaan A. Lammertsma

Publikováno v: Acta Ophthalmologica
van de Kreeke, J A, Nguyen, H-T, den Haan, J, Konijnenberg, E, Tomassen, J, den Braber, A, Ten Kate, M, Collij, L, Yaqub, M, van Berckel, B, Lammertsma, A A, Boomsma, D I, Tan, H S, Verbraak, F D & Visser, P J 2019, ' Retinal layer thickness in preclinical Alzheimer's disease ', Acta Ophthalmologica, vol. 97, no. 8, pp. 798-804 . https://doi.org/10.1111/aos.14121
Acta Ophthalmologica, 97(8), 798-804. Wiley-Blackwell

PURPOSE: There is urgent need for non-invasive diagnostic biomarkers in the preclinical phase of Alzheimer's Disease (AD). Several studies suggest that retinal thickness is reduced in AD. Here, we aim to test the diagnostic value of retinal thickness

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3341d2594bc2819f2e1851935f900324
http://europepmc.org/articles/PMC6900176

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The EMIF-AD PreclinAD study

Autor: Pieter Jelle Visser, Neil Pendleton, Maqsood Yaqub, Elles Konijnenberg, Annette C. Moll, Karl Herholz, Chinenye Amadi, Erik H. Serné, Frederik Barkhof, Mara ten Kate, Frank D. Verbraak, Sandra D. Mulder, Dorret I. Boomsma, Jacoba A. van de Kreeke, Philip Scheltens, Linda M.P. Wesselman, Femke H. Bouwman, Matteo Demuru, Charlotte E. Teunissen, Rainer Hinz, Hoang Ton Nguyen, Jori Tomassen, Bart N.M. van Berckel, Anouk den Braber, Stephen F. Carter, Adriaan A. Lammertsma, Arjan Hillebrand

Publikováno v: Alzheimer's Research & Therapy, 10:75. BioMed Central Ltd
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-12 (2018)
Konijnenberg, E, Carter, S F, Ten Kate, M, Den Braber, A, Tomassen, J, Amadi, C, Wesselman, L, Nguyen, H T, Van De Kreeke, J A, Yaqub, M, Demuru, M, Mulder, S D, Hillebrand, A, Bouwman, F H, Teunissen, C E, Serné, E H, Moll, A C, Verbraak, F D, Hinz, R, Pendleton, N, Lammertsma, A A, Van Berckel, B N M, Barkhof, F, Boomsma, D I, Scheltens, P, Herholz, K & Visser, P J 2018, ' The EMIF-AD PreclinAD study : Study design and baseline cohort overview ', Alzheimer's Research and Therapy, vol. 10, 75, pp. 1-12 . https://doi.org/10.1186/s13195-018-0406-7
Alzheimer's Research & Therapy, 10(1). BioMed Central
Alzheimer's Research & Therapy
Konijnenberg, E, Carter, S F, Ten Kate, M, den Braber, A, Tomassen, J, Amadi, C, Wesselman, L, Nguyen, H-T, van de Kreeke, J A, Yaqub, M, Demuru, M, Mulder, S D, Hillebrand, A, Bouwman, F H, Teunissen, C E, Serné, E H, Moll, A C, Verbraak, F D, Hinz, R, Pendleton, N, Lammertsma, A A, van Berckel, B N M, Barkhof, F, Boomsma, D I, Scheltens, P, Herholz, K & Visser, P J 2018, ' The EMIF-AD PreclinAD study : study design and baseline cohort overview ', Alzheimer's Research & Therapy, vol. 10, no. 1, pp. 75 . https://doi.org/10.1186/s13195-018-0406-7

Background Amyloid pathology is the pathological hallmark in Alzheimer’s disease (AD) and can precede clinical dementia by decades. So far it remains unclear how amyloid pathology leads to cognitive impairment and dementia. To design AD prevention

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ea63b2cc999a05464ee384e9d201046
https://doi.org/10.1186/s13195-018-0406-7

Additional file 3: of The EMIF-AD PreclinAD study: study design and baseline cohort overview

Autor: Konijnenberg, Elles, Carter, Stephen, Kate, Mara Ten, Braber, Anouk Den, Tomassen, Jori, Chinenye Amadi, Wesselman, Linda, Hoang-Ton Nguyen, Kreeke, Jacoba Van De, Yaqub, Maqsood, Demuru, Matteo, Mulder, Sandra, Hillebrand, Arjan, Bouwman, Femke, Teunissen, Charlotte, SernĂŠ, Erik, Moll, Annette, Verbraak, Frank, Hinz, Rainer, Pendleton, Neil, Lammertsma, Adriaan, Berckel, Bart Van, Barkhof, Frederik, Dorret Boomsma, Scheltens, Philip, Herholz, Karl, Visser, Pieter

Table S3. Questionnaires baseline. (DOCX 37Â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280e0816739ec5393e03874e55eed0e6